Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy.

Saved in:
Bibliographic Details
Title: Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy.
Authors: Steenbeek MP; Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Obstetrics and Gynecology, Nijmegen, the Netherlands., van Bommel MHD; Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Obstetrics and Gynecology, Nijmegen, the Netherlands. Electronic address: Majke.vanBommel@radboudumc.nl., Harmsen MG; Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Obstetrics and Gynecology, Nijmegen, the Netherlands., Hoogerbrugge N; Radboud University Medical Center, Department of Human Genetics, PO Box 9101, 6500, HB, Nijmegen, the Netherlands., van Doorn HC; Department of Gynecology, Erasmus MC Cancer Clinic, 's, Gravendijkwal 230, 3015, CE, Rotterdam, the Netherlands., Keurentjes JHM; Department of Gynecologic Oncology, University of Groningen, University Medical Centre Groningen, Hanzeplein 1, 9713, GZ, Groningen, the Netherlands., van Beurden M; Centre for Gynecological Oncology Amsterdam (CGOA), Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066, CX, Amsterdam, the Netherlands., Zweemer RP; Department of Gynecological Oncology, UMC Utrecht Cancer Centre, Heidelberglaan 100, 3584, CX, Utrecht, the Netherlands., Gaarenstroom KN; Department of Obstetrics and Gynecology, Leiden University Medical Centre, Albinusdreef 2, 2333, ZA, Leiden, the Netherlands., Penders CGJ; Department of Obstetrics and Gynecology, Maastricht University Medical Centre, GROW-School for Oncology and Developmental Biology, P. Debyelaan 25, 6229 HX Maastricht, the Netherlands., Brood-van Zanten MMA; Department of Obstetrics and Gynaecology, Amsterdam UMC, Meibergdreef 9, 1105, AZ, Amsterdam, the Netherlands; Department of Obstetrics and Gynecology, Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066, CX, Amsterdam, the Netherlands., Vos MC; Gynecologic Oncologic Centre South location Elisabeth-TweeSteden Hospital, Hilvarenbeekseweg 60, 5000, LC, Tilburg, the Netherlands., Piek JM; Gynecologic Oncologic Centre South location Catharina Hospital, Michelangelolaan 2, 5623 EJ Eindhoven, the Netherlands., van Lonkhuijzen LRCW; Department of Obstetrics and Gynaecology, Amsterdam UMC, Meibergdreef 9, 1105, AZ, Amsterdam, the Netherlands., Apperloo MJA; Department of Obstetrics and Gynecology, Medical Centre Leeuwarden, Henri Dunantweg 2, 8934, AD, Leeuwarden, the Netherlands., Coppus SFPJ; Department of Obstetrics and Gynecology, Maxima Medical Centre, De Run 4600, 5504, DB, Veldhoven, the Netherlands., IntHout J; Radboud University Medical Center, Radboud Institute for Health Sciences, Department for Health Evidence, PO Box 9101, 6500, HB, Nijmegen, the Netherlands., de Hullu JA; Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Obstetrics and Gynecology, Nijmegen, the Netherlands., Hermens RPMG; Radboud University Medical Center, Scientific Institute for Quality of Healthcare, PO Box 9101, 6500, HB, Nijmegen, the Netherlands.
Source: Gynecologic oncology [Gynecol Oncol] 2021 Nov; Vol. 163 (2), pp. 371-377. Date of Electronic Publication: 2021 Aug 27.
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34456057
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Steenbeek+MP%22">Steenbeek MP</searchLink>; Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Obstetrics and Gynecology, Nijmegen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Bommel+MHD%22">van Bommel MHD</searchLink>; Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Obstetrics and Gynecology, Nijmegen, the Netherlands. Electronic address: Majke.vanBommel@radboudumc.nl.<br /><searchLink fieldCode="AU" term="%22Harmsen+MG%22">Harmsen MG</searchLink>; Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Obstetrics and Gynecology, Nijmegen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Hoogerbrugge+N%22">Hoogerbrugge N</searchLink>; Radboud University Medical Center, Department of Human Genetics, PO Box 9101, 6500, HB, Nijmegen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Doorn+HC%22">van Doorn HC</searchLink>; Department of Gynecology, Erasmus MC Cancer Clinic, 's, Gravendijkwal 230, 3015, CE, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Keurentjes+JHM%22">Keurentjes JHM</searchLink>; Department of Gynecologic Oncology, University of Groningen, University Medical Centre Groningen, Hanzeplein 1, 9713, GZ, Groningen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Beurden+M%22">van Beurden M</searchLink>; Centre for Gynecological Oncology Amsterdam (CGOA), Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066, CX, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Zweemer+RP%22">Zweemer RP</searchLink>; Department of Gynecological Oncology, UMC Utrecht Cancer Centre, Heidelberglaan 100, 3584, CX, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Gaarenstroom+KN%22">Gaarenstroom KN</searchLink>; Department of Obstetrics and Gynecology, Leiden University Medical Centre, Albinusdreef 2, 2333, ZA, Leiden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Penders+CGJ%22">Penders CGJ</searchLink>; Department of Obstetrics and Gynecology, Maastricht University Medical Centre, GROW-School for Oncology and Developmental Biology, P. Debyelaan 25, 6229 HX Maastricht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Brood-van+Zanten+MMA%22">Brood-van Zanten MMA</searchLink>; Department of Obstetrics and Gynaecology, Amsterdam UMC, Meibergdreef 9, 1105, AZ, Amsterdam, the Netherlands; Department of Obstetrics and Gynecology, Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066, CX, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Vos+MC%22">Vos MC</searchLink>; Gynecologic Oncologic Centre South location Elisabeth-TweeSteden Hospital, Hilvarenbeekseweg 60, 5000, LC, Tilburg, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Piek+JM%22">Piek JM</searchLink>; Gynecologic Oncologic Centre South location Catharina Hospital, Michelangelolaan 2, 5623 EJ Eindhoven, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Lonkhuijzen+LRCW%22">van Lonkhuijzen LRCW</searchLink>; Department of Obstetrics and Gynaecology, Amsterdam UMC, Meibergdreef 9, 1105, AZ, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Apperloo+MJA%22">Apperloo MJA</searchLink>; Department of Obstetrics and Gynecology, Medical Centre Leeuwarden, Henri Dunantweg 2, 8934, AD, Leeuwarden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Coppus+SFPJ%22">Coppus SFPJ</searchLink>; Department of Obstetrics and Gynecology, Maxima Medical Centre, De Run 4600, 5504, DB, Veldhoven, the Netherlands.<br /><searchLink fieldCode="AU" term="%22IntHout+J%22">IntHout J</searchLink>; Radboud University Medical Center, Radboud Institute for Health Sciences, Department for Health Evidence, PO Box 9101, 6500, HB, Nijmegen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22de+Hullu+JA%22">de Hullu JA</searchLink>; Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Obstetrics and Gynecology, Nijmegen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Hermens+RPMG%22">Hermens RPMG</searchLink>; Radboud University Medical Center, Scientific Institute for Quality of Healthcare, PO Box 9101, 6500, HB, Nijmegen, the Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220365304%22">Gynecologic oncology</searchLink> [Gynecol Oncol] 2021 Nov; Vol. 163 (2), pp. 371-377. <i>Date of Electronic Publication: </i>2021 Aug 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Academic+Press%22">Academic Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0365304 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1095-6859 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200908258%22">00908258 </searchLink><i>NLM ISO Abbreviation: </i>Gynecol Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34456057
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ygyno.2021.08.019
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 371
    Titles:
      – TitleFull: Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Steenbeek MP
      – PersonEntity:
          Name:
            NameFull: van Bommel MHD
      – PersonEntity:
          Name:
            NameFull: Harmsen MG
      – PersonEntity:
          Name:
            NameFull: Hoogerbrugge N
      – PersonEntity:
          Name:
            NameFull: van Doorn HC
      – PersonEntity:
          Name:
            NameFull: Keurentjes JHM
      – PersonEntity:
          Name:
            NameFull: van Beurden M
      – PersonEntity:
          Name:
            NameFull: Zweemer RP
      – PersonEntity:
          Name:
            NameFull: Gaarenstroom KN
      – PersonEntity:
          Name:
            NameFull: Penders CGJ
      – PersonEntity:
          Name:
            NameFull: Brood-van Zanten MMA
      – PersonEntity:
          Name:
            NameFull: Vos MC
      – PersonEntity:
          Name:
            NameFull: Piek JM
      – PersonEntity:
          Name:
            NameFull: van Lonkhuijzen LRCW
      – PersonEntity:
          Name:
            NameFull: Apperloo MJA
      – PersonEntity:
          Name:
            NameFull: Coppus SFPJ
      – PersonEntity:
          Name:
            NameFull: IntHout J
      – PersonEntity:
          Name:
            NameFull: de Hullu JA
      – PersonEntity:
          Name:
            NameFull: Hermens RPMG
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2021 Nov
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1095-6859
          Numbering:
            – Type: volume
              Value: 163
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Gynecologic oncology
              Type: main
ResultId 1